In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

Painful chemotherapy-induced peripheral neuropathy

(2017) Jennifer S. Gewandter et al.   PAIN

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

(2017) Jacobien M. Kieffer et al.   QUALITY OF LIFE RESEARCH

Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy

(2017) Robert Knoerl et al.   SUPPORTIVE CARE IN CANCER

Cancer treatment and survivorship statistics, 2016

(2016) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Chemotherapy-Related Neurotoxicity

(2016) Sophie Taillibert et al.   Current Neurology and Neuroscience Reports

North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study

(2014) Alexis D. Leal et al.   CANCER

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

(2013) P. Alberti et al.   ANNALS OF ONCOLOGY

Measuring Vincristine-Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia

(2013) Ellen M. Lavoie Smith et al.   CANCER NURSING

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

(2013) Ellen M. Lavoie Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

(2013) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

(2013) Ellen M. Lavoie Smith et al.   QUALITY OF LIFE RESEARCH

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy

(2012) Brandi N. Reeves et al.   CANCER

The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers

(2012) Laura S. Gilchrist et al.   SUPPORTIVE CARE IN CANCER

Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

(2011) Andreas A. Argyriou et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1

(2011) Charles L. Loprinzi et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale

(2011) Barbara Frigeni et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer

(2011) O. Arrieta et al.   NEUROLOGY

Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy

(2010) Wen-Yee CHAY et al.   Asia-Pacific Journal of Clinical Oncology

The Reliability and Validity of a Modified Total Neuropathy Score-Reduced and Neuropathic Pain Severity Items When Used to Measure Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxanes and Platinums

(2010) Ellen M. Lavoie Smith et al.   CANCER NURSING

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study

(2010) Keiichiro Ishibashi et al.   International Journal of Clinical Oncology

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

(2010) Axel Grothey et al.   JOURNAL OF CLINICAL ONCOLOGY

Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties

(2010) Kathleen A. Griffith et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial

(2010) Lisa A. Kottschade et al.   SUPPORTIVE CARE IN CANCER

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

(2010) Debra L. Barton et al.   SUPPORTIVE CARE IN CANCER

Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity

(2009) Paola Milla et al.   ANTI-CANCER DRUGS

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms

(2007) Anna-Liisa Kautio et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT